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Comprehensive profiling of zebrafish hepatic
proximal promoter CpG island methylation and
its modification during chemical carcinogenesis
Leda Mirbahai1*, Timothy D Williams1, Huiqing Zhan2, Zhiyuan Gong2, J Kevin Chipman1
Abstract
Background: DNA methylation is an epigenetic mechanism associated with regulation of gene expression and it is
modulated during chemical carcinogenesis. The zebrafish is increasingly employed as a human disease model;
however there is a lack of information on DNA methylation in zebrafish and during fish tumorigenesis.
Results: A novel CpG island tiling array containing 44,000 probes, in combination with immunoprecipitation of
methylated DNA, was used to achieve the first comprehensive methylation profiling of normal adult zebrafish liver.
DNA methylation alterations were detected in zebrafish liver tumors induced by the environmental carcinogen 7,
12-dimethylbenz(a)anthracene. Genes significantly hypomethylated in tumors were associated particularly with
proliferation, glycolysis, transcription, cell cycle, apoptosis, growth and metastasis. Hypermethylated genes included
those associated with anti-angiogenesis and cellular adhesion. Of 49 genes that were altered in expression within
tumors, and which also had appropriate CpG islands and were co-represented on the tiling array, approximately
45% showed significant changes in both gene expression and methylation.
Conclusion: The functional pathways containing differentially methylated genes in zebrafish hepatocellular
carcinoma have also been reported to be aberrantly methylated during tumorigenesis in humans. These findings
increase the confidence in the use of zebrafish as a model for human cancer in addition to providing the first
comprehensive mapping of DNA methylation in the normal adult zebrafish liver.
Background
Tumorigenesis by chemical carcinogens is a multistep
process [1] with accumulation of both mutations and
epigenetic aberrations in regulatory regions of genes and
disruption of cellular signaling pathways [2,3]. In parti-
cular, DNA methylation at CpG dinucleotides is an
important component of epigenetic gene expression reg-
ulation [4], resulting in modulation of protein-DNA
interactions [5,6]. Aberrant methylation of CpG islands
(CGI) in the promoter and exonic regions [7,8], and
changes in gene expression, have been associated with
tumorigenesis [7,9,10]. Global hypomethylation occurs
in most human tumors [3,4,7] leading to potential acti-
vation of imprinted genes, parasite sequences and onco-
genes and increased chromosome instability [3]. In
addition, hypermethylation of genes associated with
negative regulation of tumorigenesis, such as tumor sup-
pressor genes (TSG), DNA repair genes, and anti-angio-
genic genes, is a common and key characteristic of
neoplastic cells [4,10-13]. Furthermore, a range of
rodent carcinogens alter methylation status contributing
to the carcinogenic mechanisms [14].
Fish have been used as models to study tumors
induced by environmental carcinogens. For example,
rainbow trout (Oncorhynchus mykiss) [15], zebrafish
(Danio rerio) [16], guppy (Poecilia reticulata) [17], platy-
fish (Xiphophorus sp.) [18] and medaka (Oryzias latipes)
[17] have been employed in carcinogen bioassays. Zebra-
fish is a particularly well established model for investi-
gating embryogenesis, organogenesis, environmental
carcinogenesis and for modeling human diseases such as
cancer [15,19-23]. Chemically-induced tumors in zebra-
fish and tumors in humans are histopathologically very
similar [20,24] and orthologous TSGs and oncogenes in
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human and fish have been identified [20]. Recent studies
comparing hepatic gene expression in human and zebra-
fish tumors demonstrated conservation of gene expres-
sion profiles at different stages of tumor aggressiveness
between these two phylogenetically distant species [23].
However, the contribution of altered methylation to
such changes is unknown.
Although there are reports on global levels of methy-
lation during embryogenesis or in adults [25-27], effect
of temperature on global levels of methylation [28]
methylation profiling in zebrafish embryo [29] and role
of chromatin mediated gene regulation during embryo-
genesis [19], to our knowledge no study has been pub-
lished on the DNA methylation patterns or methylation
changes associated with carcinogenesis in adult zebra-
fish. Therefore, the aims of the study were to achieve a
comprehensive mapping of zebrafish hepatic proximal
promoter CGI methylation in both normal liver and in
chemically induced hepatocellular carcinoma (HCC)
tumors. We aimed to determine if there was a linkage
between methylation and the observed changes in the
zebrafish HCC gene expression, and to compare biologi-
cal pathways represented by altered gene methylation in
zebrafish HCC with pathways commonly altered in
human HCC.
To our knowledge this paper is the first to describe
methyl-DNA immunoprecipitation (MeDIP) in combina-
tion with a CGI zebrafish tiling array for establishing
normal and HCC methylation profiles in the liver of any
adult fish species. This microarray, in combination with
well-established methylation immunoprecipitation,
serves as a powerful tool for elucidating comprehensive
methylation profiles. To further validate the data derived
from the tiling array, bisulfite sequencing PCR was used.
Results
Global measurement of DNA methylation
To establish the global level of cytosine methylation in
zebrafish liver in comparison to mammals, reverse-
phase high performance liquid chromatography (HPLC)
was performed (Figure 1A). Absence of RNA contami-
nation was confirmed using uracil as a reference mate-
rial. As shown in Figure 1B, zebrafish liver has a
statistically significant 2.14 fold higher methylation level
(p-value <0.01) than that of calf (Bos taurus) thymus.
This is in agreement with previous published data show-
ing higher levels of DNA methylation in fish compared
to mammals [27].
Unbiased enrichment of methylated DNA using methyl-
DNA immunoprecipitation (MeDIP)
To optimize and test the specificity of the immunopreci-
pitation method, CGI regions of 14 genes (15 regions)
located 1.5 kb upstream to 1 kb downstream of
transcriptional start sites (TSS) were screened for
methylation of cytosine using bisulfite sequencing PCR
(Additional file 1, Table S1). Following bisulfite treat-
ment and sequencing of the 14 genes, CGIs located at
the promoter region of the “no-tail“ (ntla) gene were
found to be completely methylated while the remaining
13 genes, including glutathione S- transferase P1 (gstp1),
were completely un-methylated (Additional file 2,
Figures S1 and S2). The no-tail gene and the glutathione
S-transferase P1 gene were thus used as fully methylated
(positive control) and un-methylated (negative control)
DNA regions for validating the immunoprecipitation
enrichment method.
DNA was immunoprecipitated and bisulfite-treated.
Equal amounts of immunoprecipitated, bisulfite-treated
DNA were amplified for the two genes of interest. The
gel images achieved indicated a clear enrichment of
methylated ntla gene in comparison to un-methylated
glutathione S-transferase P1 using 5-methyl cytosine
antibody (the primers used and the regions amplified
are shown in Additional file 3, Table S1 and the gel
electrophoresis image is shown in Additional file 4,
Figure S1).
Design of CGI (1.5 kb upstream to 1 kb downstream of
TSS) zebrafish tiling array and comprehensive mapping of
adult zebrafish liver
Probes (43,960) were designed to cover the CGIs located
1.5 kb upstream to 1 kb downstream of the TSS of 6,024
genes. A list of genes with predicted CGIs, number of
CGIs for each chromosome and location on the chromo-
some are presented in Additional file 5, Table S1. Where
possible, 60-mer probes were tiled over the CGIs with 25
bp spacing, covering the entire region (Figure 2). The
negative control consisted of PCR amplified genomic
DNA, immunoprecipitated and labeled with Cy-5. As
methylation is removed during amplification little DNA
was precipitated as expected. A uniform low intensity
signal was measured for all probes represented on the
array (Additional file 6, Table S1) representing non-
specific binding of DNA to the 5-methylcytosine anti-
body. The positive control was achieved by treatment
of DNA with CpG methyltransferase (Sss I) in the pre-
sence of S-adenosylmethionine (SAM) prior to MeDIP.
This resulted in complete methylation of all CGIs and
detection of a uniformly high fluorescent signal for all
probes (Additional file 6, Table S1). Using our CGI til-
ing array we achieved a comprehensive mapping of the
DNA methylation at CGIs in adult zebrafish liver at
the 1.5 kb upstream to 1 kb downstream of gene TSS.
The list of all genes on the tiling array and their
methylation levels are presented in Additional file 6,
Table S4. Those genes with values 2 fold above the
median level (higher methylation) and 2 fold below the
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Figure 1 Measurement of global percentage of methylated DNA in zebrafish and calf using HPLC. A. Determination of the retention time
of five standard mononucleotides using HPLC. An arrow indicates absence of uracil peak showing that the sample is not contaminated with
RNA. B. Percentage of DNA methylated in healthy zebrafish (D.rerio) and calf (B.taurus) thymus. Global percentage of methylated DNA in zebrafish
is 2.14 fold higher than calf. Data are the mean ± SEM of three independent experiments. ** Significantly different from calf (p < 0.01).
Figure 2 Chromosomal mapping of the probes. A. All probes were mapped onto zebrafish chromosomes. As an example, probes for coronin,
actin binding protein 2ba gene (coro2ba; ENSDARG00000079440) on chromosome 7 are shown. A CGI was predicted at the region between
33649014 and 33649398. Colors indicate the intensity of the probe fluorescent signal (red: hypermethylation, yellow: no change, blue:
hypomethylation). B. The mean fold changes between control and tumor samples for each probe are shown.
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median level (lower methylation) in control are high-
lighted. Gene ontology analysis using Blast2GO identi-
fied GO terms significantly (False Discovery Rate
(FDR) <5%) over-represented amongst lower- and
higher-methylated genes in control samples. For lower
methylated genes, the GO terms were related particu-
larly to involvement in hormone secretion, cellular
response to hormone stimulation, regulation of tran-
scription, sex determination (dmrt), and regulation of
apoptosis (Figure 3). Higher methylated genes included
those involved in molecular transducer activity and the
connexin complex (Figure 4).
Methylation analysis of zebrafish hepatocellular
carcinoma and comparison to gene expression
DNA extracted from zebrafish HCC was processed by
MeDIP, labeled with fluorescent Cy5-dCTP and hybri-
dized to the tiling array against input genomic DNA.
Following quality checks and normalization, probes were
mapped onto the chromosomes and two lists, containing
hypomethylated and hypermethylated regions in com-
parison to control, were generated (fold change >1.5,
p-value <0.05). It was apparent that most differentially
methylated regions in HCC were hypomethylated (712
probes) in comparison to 168 hypermethylated regions.
Examples of genes relevant to cancer that contained
aberrant methylation are shown in Table 1 (the full list
of genes and gene ontology analyses are presented in
Additional file 6, Tables S2 and S3). Using a principal
components analysis (PCA) scores plot of differentially
methylated regions, the four groups of HCC, controls,
positive and negative control were separated based on
treatment along the PC1 and PC2 axes (Figure 5). Gene
ontology analysis using Blast2GO was carried out to
find changes in GO term representation in lists of hypo-
methylated and hypermethylated genes. Functionally
related genes with statistically significant differential
methylation between tumors and controls are presented
in Figure 6 (False Discovery Rate (FDR) <10%).
In addition to Blast2GO, Ingenuity Pathway Analysis
(IPA) was performed to characterize the functional rela-
tionships between genes that were altered in methyla-
tion in tumors compared to control. Figure 7 illustrates
hypomethylated genes in zebrafish tumors (fold change
>1.5) related to the canonical pathway “molecular
mechanisms of cancer” in humans these included c-jun,
shc and p21.
IPA identified significant networks, top functions and
canonical pathways associated with the differentially
methylated genes for each comparison analyzed. Signifi-
cantly over represented (FDR <5%) categories of func-
tions for both hypo- and hyper-methylated genes in
zebrafish HCC are shown in Additional file 7, tables S1
and S2.
In a previous study [23], gene expression changes in
zebrafish HCC produced by the same chemical treat-
ment were profiled. We used data from this study to
compare alteration in gene expression with DNA
methylation in HCC samples. Comparisons are limited
to the genes represented on both the expression array
and the CGI tiling array. Expression of 194 genes that
significantly differed between healthy and zebrafish
HCC were investigated for methylation. From the 194
genes with altered gene expression, 68 genes had CGIs
at the 1.5 kb upstream to 1 kb downstream of TSS.
Due to the criteria used for designing probes, only 49
genes from the previously identified 68 genes were
represented on the tiling array and were investigated for
comparison of DNA methylation level with gene expres-
sion. In total 22 genes were identified showing both sig-
nificantly altered transcription and methylation (> 1.5
fold change) in zebrafish HCC (Table 2, A full list of
the 194 genes investigated is presented in Additional
file 8, Table S1). Most genes identified were hypomethy-
lated with up-regulated gene expression, such as mito-
gen-activated protein kinase 1 (mapk1), cell division
protein kinase 8 (cdk8), RAB2A, member ras oncogene
family (rab2) and proliferating cell nuclear antigen
(pcna). IPA was applied to the list of genes that were
significantly hypomethylated with up-regulated gene
expression. The networks highlighted (Figure 8) con-
tained molecules involved in formation of cancer, prolif-
eration and transformation of cells in humans. For
example, pcna is involved in formation of the replica-
tion fork and directs maintenance methyltransferases to
the newly synthesized DNA strand. Mapk1, capn2 and
erk were additional molecules linked with human
tumorigenesis.
Confirmation of the CGI tiling array data using bisulfite
sequencing PCR
Based on the data obtained from the methylation tiling
array, six genes from 3 different categories of hypo-
methylated, hypermethylated and genes showing no sig-
nificant change between tumor and healthy tissue based
on microarray analysis were selected for validation of
the array data by bisulfite sequencing PCR (three tumor
samples and three control samples). Bisulfite sequencing
PCR provided a detailed analysis of the methylation sta-
tus of individual CpGs within the amplified regions [30].
The glutathione S-transferase P1 CGI, as shown in
Additional file 2, Figure S1, is un-methylated in both
tumor and control samples. Following treatment with
CpG methyltransferase (SssI) in the presence of SAM, it
became fully methylated (Additional file 2, Figure S3).
This artificially methylated gene was used as a positive
control to confirm our semi-quantitative measurements
of DNA methylation.
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Figure 3 Gene ontology (GO) terms significantly over-represented in the genes with DNA methylation levels 2 fold below the median level in zebrafish healthy liver i.e. lower
methylation level (FDR< 5%). These data are derived from those shown in Additional file 6, Table S4 which displays the mean normalized fluorescence intensity for 4 healthy zebrafish liver
samples for all probes that passed filtering steps.
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Figure 4 Gene ontology (GO) terms significantly over-represented in the genes with DNA methylation levels 2 fold above the median level in zebrafish healthy liver i.e. higher
methylation level (FDR< 5%). These data are derived from those shown in Additional file 6, Table S4 which displays the mean normalized fluorescence intensity for 4 healthy zebrafish liver
samples for all probes that passed filtering steps.
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Table 1 Identified genes with altered methylation in zebrafish HCC
Gene name Gene ID Chr. no CGI region
A. Hypomethylated Genes
Proliferation
Kruppel-like factor 12b ENSDARG00000032197 9 31117162 - 31117483
Insulin-like growth factor binding protein 5a ENSDARG00000025348 9 49194032 - 49194791
Insulin-like growth factor binding protein 2a ENSDARG00000031422 9 49290381 - 49290816
Insulin-like growth factor binding protein 1b ENSDARG00000038666 2 178184 - 178306
Insulin-like growth factor-binding protein 2A precursor ENSDARG00000052470 6 22745784 - 22746301
Estrogen related receptor delta fragment ENSDARG00000015064 18 48225445 - 48225631
Hypothetical protein LOC550398 ENSDARG00000043587 1 51038733 - 51038845
Stress
Similar to SH2 domain containing 3C ENSDARG00000028099 10 14303115 - 14303263
PI-kinase-related SMG-1 ENSDARG00000054570 3 28544220 - 28544532
Glycolysis
Enolase 2 ENSDARG00000014287 19 4698036 - 4698168
Hexokinase 1 ENSDARG00000039452 13 23684991 - 23685203
Cell cycle, metastasis, adhesion, cell growth, stress
c-Jun protein ENSDARG00000043531 20 14274343 - 14274635
BCL2-associated athanogene 5 ENSDARG00000017316 13 17324708 - 17324877
Angiopoietin-like 3 ENSDARG00000044365 6 34165085 - 34165237
Angiopoietin-1 receptor precursor ENSDARG00000028663 5 625275 - 625436
Ras homolog gene family, member Ua ENSDARG00000019709 13 25136705 - 25136882
Menage a trois homolog 1 ENSDARG00000002077 13 31141636 - 31142019
Serine/threonine and tyrosine protein kinase ENSDARG00000000853 22 461194 - 461772
DNA binding and regulation of transcription
DNA (cytosine-5-)-methyltransferase 6 ENSDARG00000015566 17 34759411 - 34759539
Leucine zipper protein 2 precursor ENSDARG00000068247 18 35625841 - 35625986
Histone H2A ENSDARG00000001915 1 724191 - 724473
Histone deacetylase 4 ENSDARG00000041204 9 46375505 - 46375895
Homeobox protein Hox-B5a ENSDARG00000013057 3 20707021 - 20707754
Pancreas transcription factor 1 subunit alpha ENSDARG00000014479 2 27672474 - 27672641
Hypothetical protein LOC692291 ENSDARG00000012833 17 12689887 - 12690054
Metastasis associated 1 family, member 2 ENSDARG00000013031 7 17243535 - 17244290
Homeobox protein Hox-B4a ENSDARG00000013533 3 20721064 - 20721722
Lysine-specific demethylase 4A ENSDARG00000018782 6 4575451 - 4575994
RAB11 family interacting protein 4 (class II) a ENSDARG00000053855 25 13380260 - 13380369
B. Hypermethylated Genes
Anti-angiogenesis
Hematopoietically-expressed homeobox protein hhex ENSDARG00000074250 12 43558447 - 43558684
Cell-cell adhesion
Hypothetical protein LOC678612 ENSDARG00000069505 21 27963202 - 27963305
Novel protocadherin protein fragment ENSDARG00000053462 1 55112983 - 55113251
Transporter
ATP-binding cassette, sub-family A, member 5 ENSDARG00000074041 12 38940033 - 38940251
immune system
Novel protein similar to nuclear factor, interleukin 3 regulated ENSDARG00000071398 22 21400978 - 21401243
Novel protein fragment ENSDARG00000053462 1 55112983 - 55113251
C5a anaphylatoxin chemotactic receptor ENSDARG00000040319 18 45692130 - 45692420
Angiogenesis and oxidative stress protection
Vascular endothelial zinc finger 1 ENSDARG00000008247 10 35492470 - 35493037
Membrane
Coronin, actin binding protein 2ba ENSDARG00000079440 7 33649014 - 33649398
A. Genes identified as hypomethylated in HCC as measured by CGI-tiling array (1.5-fold less methylation in tumor samples than controls, P-value < 0.05). B. Genes
identified as hypermethylated in HCC as measured by CGI-tiling array (1.5-fold more methylation in tumor samples than controls, P-value < 0.05). Full data is
shown in Additional file 6, Tables S2 and S3.
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Direct sequencing of bisulfite-treated and amplified
DNA was used for measurement of average methylation
percentage in a population of DNA molecules. Both
normal and tumor tissues are heterogeneous in terms of
molecular alterations and cell populations. As in this
study DNA was extracted from a tissue with a mixture
of cell populations, complete homogeneity of the
sequence data was not anticipated. Therefore, the pro-
portion of C/T was compared between samples based
on well established methodology previously utilized
[31-33]. Direct sequencing of bisulfite treated amplified
DNA (as well as allowing the detection of partial and
rare events [34]) provided an average methylation per-
centage at particular CpG sites in a population of DNA
molecules. This is in contrast to establishment of the
methylation status of a CpG in one molecule achieved
by cloning prior to sequencing [31-34]. The genes
selected for additional analysis using bisulfite sequencing
PCR (BSP) were coronin, actin binding protein 2ba (cor-
o2ba) (hypermethylated in HCC), insulin-like growth
factor binding protein 1b (igfbp1b) and angiopoietin-like
3 (angptl3) (hypomethylated in HCC), no-tail (ntla) (no
change) and S-adenosylhomocysteine hydrolase-like 2
Figure 5 Principal component analysis (PCA) scores plot of
DNA methylation data. Zebrafish HCC samples (purple), healthy
zebrafish liver samples (orange), positive control of artificially
methylated genomic DNA (green) and negative control of artificially
un-methylated genomic DNA (yellow) were separated based on
treatment along the PC1 and PC2 axes.
Figure 6 Gene ontology (GO) terms significantly over-represented in the list of genes hypomethylated in zebrafish HCC compared to
control (FDR< 10%).
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(ahcyl2) and inhibitor of DNA binding 2 (id2a) (showed
no statistically significant change). The primers and
annealing temperatures used are shown in Additional
file 3, Table S1. Measurement of peak area for C and T
at a particular CpG site and calculation of the percen-
tage of methylation in four-dye trace sequencing data
allowed a semi-quantitative assessment of the methyla-
tion level at the specific site. To compare the methyla-
tion status of the targeted area by BSP in tumor and
control, the total amount of methylation for the region
was measured and compared for tumor and control.
Bisulfite sequencing PCR results for insulin-like growth
Figure 7 Biological network of genes linked to the canonical pathway “molecular mechanisms of cancer” that were hypomethylated
(fold change >1.5) in zebrafish hepatocellular carcinoma compared to healthy liver. This diagram shows the genes that were
hypomethylated in zebrafish HCC with grey shading. Additionally, orange outlines indicate the molecules associated with the hypomethylated
genes via Ingenuity pathways. Direct interactions are shown as solid lines and indirect as dashed lines. Biological network analysis was
performed using Ingenuity Pathway Analysis.
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factor protein 1b, coronin-actin binding protein 2ba and
angiopoietin-like 3 confirmed the changes observed from
the tiling array (Figure 9, sequencing data are presented
in Additional file 9, Figures S1 and S2). The three genes
showing no significant difference in methylation by
microarray also showed no change in methylation
between tumor and normal samples by BSP.
Discussion
To achieve a global non-biased enrichment of the
methylated fragments of genomic DNA, methyl-DNA
immunoprecipitation (MeDIP) combined with the novel
zebrafish CpG island tiling array was used. This method
enabled us to perform the first gene-specific large scale
analysis and establishment of a comprehensive methyla-
tion map at CGIs of the regions 1.5 kb upstream to 1
kb downstream of the TSS in both healthy zebrafish
liver and in hepatocellular carcinoma.
Regulation of transcription is a complex procedure. It
is partly accomplished by formation of nucleosomes [35]
and by modulating the binding of regulatory factors and
the transcription complex to transcriptional response
elements, both directly and indirectly [1]. Epigenetic
mechanisms such as chromatin modifications, RNA
interference (RNAi) and DNA methylation are key mod-
ulators of transcription through different mechanisms,
such as prohibiting transcription factor access to their
binding sites and affecting the formation of nucleosomes
[12,35,36].
The methylation profiles of cancer cells are extensively
distorted [11]. Hypomethylation in tumors is associated
with transcriptional activation of previously suppressed
genes and is a hallmark of tumorigenesis [1,11], where
active genes are un-methylated with hyperacetylated his-
tones [12]. As shown in Table 1A, GO terms associated
with DNA binding and transcription regulation were sig-
nificantly over-represented amongst genes hypomethylated
in HCC samples. Genes including histone deacetylase 4,
DNA (cytosine-5-)-methyltransferase 6 and lysine-specific
demethylase 4A showed significant decreases in their
methylation levels in HCC samples in comparison to
healthy liver.
Comparison of the normal hepatic gene methylation
pattern between human liver, presented by Archer et al
[37], and zebrafish liver in this study showed a low corre-
lation (r2 = 0.187) implying lack of conservation of
methylation patterns between human and zebrafish.
However, our comparisons showed that, in zebrafish and
Table 2 Comparison of DNA methylation levels with gene expression levels
Gene name Symbol Chr. no Expression level Methylation level Gene ID
Matrix metalloproteinase 14 (membrane-inserted) alpha mmp14a 7 ↑ ↓ ENSDARG00000002235
Histidyl-tRNA synthetase hars 14 ↑ ↓ ENSDARG00000003693
Tubulin, alpha 8 like 4 tuba8l4 6 ↑ ↓ ENSDARG00000006260
E2F transcription factor 6 e2f6 20 ↓ ↓ ENSDARG00000008119
Acetoacetyl-CoA synthetase aacs 5 ↑ ↑ ENSDARG00000012468
Nucleophosmin 1 npm1 10 ↑ ↓ ENSDARG00000014329
Cell division protein kinase 8 (probe 54) cdk8 24 ↑ ↓ ENSDARG00000016496
Cell division protein kinase 8 (probes 21, 31) cdk8 24 ↑ ↑ ENSDARG00000016496
Hepatoma-derived growth factor-related protein 2 hdgfrp2 22 ↑ ↓ ENSDARG00000019530
RAB2A, member RAS oncogene family rab2 2 ↑ ↓ ENSDARG00000020261
LIM domain containing preferred translocation partner in lipoma lpp 6 ↑ ↓ ENSDARG00000023578
Insulin-like growth factor binding protein 5a igfbp5b 9 ↓ ↓ ENSDARG00000025348
Mitogen-activated protein kinase 1 mapk1 5 ↑ ↓ ENSDARG00000027552
Cancer susceptibility candidate gene 3 protein homolog casc3 3 ↑ ↑ ENSDARG00000029911
Hnrpa0l protein hnrpa0l 14 ↑ ↓ ENSDARG00000036161
Cyclin T2 ccnt2 9 ↑ ↓ ENSDARG00000036685
Proliferating cell nuclear antigen pcna 10 ↑ ↓ ENSDARG00000054155
Ret proto-oncogene (probes 16, 19) ret 13 ↓ ↑ ENSDARG00000055305
Ret proto-oncogene (probes 20, 24) ret 13 ↓ ↓ ENSDARG00000055305
Integrin-linked kinase (probes 8, 1) ilk 10 ↑ ↓ ENSDARG00000056964
Integrin-linked kinase (probes 6) ilk 10 ↑ ↑ ENSDARG00000056964
Novel protein similar to vertebrate threonyl-tRNA synthetase tars 18 ↑ ↑ ENSDARG00000075429
Ribonuclease inhibitor 1 rnh1 22 ↓ ↓ ENSDARG00000078234
Calpain 2, (m/II) large subunit, like capn2 22 ↑ ↓ ENSDARG00000034211
Synaptopodin-2 synp02 7 ↓ ↑ ENSDARG00000079675
Genes with both significantly altered gene expression levels and DNA methylation levels (> 1.5 fold) (expression level: ↑ up regulated, ↓ down regulated;
methylation level: ↑ hypermethylated, ↓ hypomethylated).
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Figure 8 Ingenuity network predicted for genes that were both hypomethylated and increased in expression in zebrafish HCC
(shaded red). In this diagram molecules that are part of the canonical pathway “molecular mechanisms of cancer” are indicated with a blue line.
Figure 9 Confirmation of the CGI tiling array using bisulfite sequencing PCR. A. Methylation level at each CpG site was measured in 3
independent tumors and 3 independent control samples for coro2ba ± SEM (data for angptl1 and igfbp1b is not shown; T = tumor, C = control,
region: -580 to -879). B. Percentage of DNA methylation (combined for all measured CpGs) in angptl1, igfbp1 and coro2ba genes showed
significant changes between tumor and control samples (p-value < 0.01). (angptl1: tumors: number of CpG sites = 21, controls: number of CpG
sites = 21; igfbp1b:tumors: number of CpG sites = 15, controls: number of CpG sites = 15; coro2ba: tumors: number of CpG sites = 41, controls:
number of CpG sites = 41 ± SEM).
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human HCC tumors, similar gene families and genes
involved in shared pathways are altered in terms of
methylation. For example, zebrafish HCC samples
showed methylation changes in genes involved in prolif-
eration, cell cycle, metastasis, apoptosis, energy produc-
tion, adhesion, stress, DNA binding and regulation of
transcription (Table 1A, B and Additional file 6, Tables
S2 and S3), similar to the biological processes that con-
tain genes with altered methylation in human HCC [2].
Several other genes from families such as ABCA, CHST,
DHX, KCTD, MEGF, MYO, NPY, RNF and TBCID were
found to be hypermethylated in both zebrafish and
human HCC [38]. Ingenuity Pathway Analysis indicated
that the genes with altered methylation in zebrafish hepa-
tocellular carcinoma were associated with biological func-
tions such as cell death, cell morphology, inflammatory
response, DNA repair and replication and induced mole-
cules involved in cancer formation such as c-jun, shc and
pka. These functions and molecules are commonly
altered in human cancers. We have associated changes in
methylation of these particular genes with changes in
gene expression during tumorigenesis. The changes in
methylation levels of these particular genes and pathways
could be directly or indirectly linked to their altered
expression levels during tumorigenesis.
In our study, GO terms associated with cell prolifera-
tion were significantly over-represented in the list of
hypomethylated genes in tumors which is particularly
relevant since an imbalance between regulation of cellu-
lar proliferation pathways and cell death by apoptosis
can promote the development of tumors [39]. Anti-
apoptotic genes, such as BCL-2, and their regulators, are
often over expressed in human tumors [40,41]. Our
results showed a significant decrease in the methylation
of a positive regulator of the Bcl-2 protein, bcl-2 asso-
ciated athanogene 5 (baga5) gene [40]. Changes in anti-
apoptotic pathways in zebrafish HCC were concurrent
with changes in pathways of proliferation. Insulin like
growth factors (IGF) and insulin like growth factor bind-
ing proteins (IGFBPs) play important roles in organizing
cell proliferation, apoptosis and differentiation and are
commonly deregulated in human tumors [42]. In zebra-
fish HCC, genes for several insulin growth factor bind-
ing proteins (IGFBPs) such as igfbp2b were significantly
hypomethylated. The promoter region of the human
IGFBP-2 gene is rich in CpGs and lacks a TATA box
[43]. It is therefore plausible that methylation plays an
important role in regulating the expression of this gene.
Multiple complex IGF-dependent and independent bio-
logical functions influenced by the tissue type and
pathological status have been identified for IGFBPs
[42,43]. An increased level of IGFBP-2 protein has been
reported in liver tissues and serum during human
malignancy [42,43] with a positive correlation to the
malignancy status of the tumor [43]. In contrast to its
normal role as a negative regulator of growth, increased
levels of IGFBPs in tumors have been linked to
enhanced proliferation, partly as a response to andro-
gens and hypoxia-inducible factor-1 (HIF-1) protein.
Thus, anaerobic conditions as well as IGF, can result in
increased amount of HIF-1 [44]. A lack of vascular sup-
ply at the early stages of tumorigenesis in highly prolif-
erating tumor cells results in hypoxia [44]. Under
hypoxic circumstances glycolysis becomes the dominant
pathway for energy production in tumors and glycolytic
enzymes are induced. Associated with this, the HIF-1
protein, expressed in an anaerobic environment, initiates
the transcription of several genes involved in stress and
glycolysis as well as IGFBP2 [43,44]. This is in accord
with our finding that GO terms related to glycolysis and
hypoxia pathways were more prevalent in the list of
hypomethylated genes in HCC samples. Glycolytic
enzymes such as enolase 2 (ENO2) and hexokinase 2
showed significant decreases in methylation of their
genes in HCC samples, indicating a potential increase in
expression. Increased expression of enolases such as
ENO1 and 2, as a response to hypoxia and HIF-1, has
been reported in human HCC [45]. As well as its func-
tion in energy production, ENO1 has been associated
with enhanced proliferation in HCC [45]. Therefore,
based on the functions of genes whose methylation was
significantly altered in HCC samples it appears that
there is a link between induction of IGF, IGFBPs, HIF,
anti-apoptotic and glycolytic pathways [43,44,46]. This
is similar to findings previously reported on gene
expression in human HCC implying that differential
methylation is at least partially causative of differential
gene expression in HCC.
Conclusion
In this paper we described the development of a zebra-
fish CGI tiling array and showed that in combination
with the MeDIP technique, it can be used to detect and
profile the methylation status of specific genes. We used
this method to provide a comprehensive profiling of
zebrafish liver methylation as well as establishing the
methylation changes observed in HCC.
The methylation alterations detected can help to
explain some of the changes in gene expression in HCC.
There are striking similarities between the pathways dis-
rupted by aberrant gene expression and methylation,
both within and between human and zebrafish HCC.
Achieving a better understanding of genetic and epige-
netic regulation in the zebrafish will increase the confi-
dence regarding the use of zebrafish as a convenient
model for human disease.
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Methods
All chemicals were obtained from Sigma-Aldrich, Poole,
Dorset, UK, unless otherwise stated.
Measurement of genome wide DNA methylation by HPLC
An AKTA Explorer 10 with P900 pump, automatic UV
detector (Amersham Biosciences), APEX ODS C18 col-
umn, 250 × 4.6 mm i.d., 5 μm particle size (Waters
HPLC Ltd, UK, Phenomenex, UK); and grade column
(Phenomenex, UK) were used. Following purification of
DNA using Qiagen DNA/RNA purification kit (Qiagen,
Ltd, West Sussex, UK), percentage of global DNA
methylation was quantified according to the method of
Ramsahoye [47].
Experimental procedure and sample preparation
Methyl-DNA immunoprecipitation in combination
with a CpG island tiling array was used for profiling
methylation patterns in un-treated zebrafish liver and
hepatocellular carcinoma (HCC) samples. The chemi-
cal treatment procedure and doses used for generating
zebrafish tumors are described by Zhan et al [48]. The
exposures were carried out at the National University
of Singapore and the experimental procedure was
approved by its Institutional Animal Care and Use
Committee. Briefly, three-week-old zebrafish fry were
treated with 0.75 ppm 7, 12-dimethylbenz [a]anthra-
cene (DMBA) or dimethyl sulfoxide (DMSO, vehicle
control) for 24 h and the treatment was repeated once
2 weeks later for another 24 hours with 1.25 ppm
DMBA or DMSO. Treated fish were rinsed three times
in fresh water and transferred into new tanks for
maintenance. Fish were sampled 6-10 months after
DMBA exposure. The tumor samples used for the pre-
sent study were all larger than 3 mm in diameter.
Liver tumors were sampled for histopathological diag-
nosis (histopathology images of HCC and healthy zeb-
rafish liver are presented in Additional file 10, Figure
S1 and histopathology procedures and criteria used for
recognizing HCC are explained in detail in a previous
publication 23). Briefly, criteria for classification of
liver neoplasms were based on nuclear factors
described by Goodman et al [49]. In this study, healthy
male livers (n = 4) from the vehicle control exposure
(n = 4), hepatocellular carcinoma from the DMBA
exposure (n = 4, male) and positive and negative con-
trols artificially generated from the vehicle control
exposure (detailed below) were used for MeDIP and
immunoprecipitated DNA was labeled with fluorescent
Cy5-dCTP. A non-immunoprecipitated genomic DNA
pool was used as a reference and was labeled with
fluorescent Cy3-dCTP.
Design of the 4 × 44 k format CpG island (1.5 kb
downstream to 1 kb upstream of TSS) zebrafish tiling array
Probes were designed by Genotypic (Genotypic Tech-
nology, Bangalore, India) and were synthesized and
printed by Agilent (Agilent technologies, Berkshire, UK).
The criteria described by Gardiner-Garden and From-
mer [50] for prediction of CpG islands in vertebrates
were used to predict CpG islands in zebrafish, with
minor modifications. The zebrafish genome sequence
was derived from the Ensembl data base (version 56,
genome build zv8, genome build date April 2009). For
each gene, the region 1.5 kb upstream to 1 kb down-
stream of predicted transcription start sites (TSS) was
found, using the 5’ end of each transcript as the putative
TSS. Repetitive sequences were masked and the Emboss
CpG prediction tool (European Molecular Biology
Laboratory-EBI) identified 9,192 genes containing 14,507
CpG islands. From the preliminary list of genes (9,192),
60-mer probes were designed with an average spacing of
25 bp where possible. Due to the requirements for
probe specificity, probes could not be constructed for all
predicted CGIs. Probes with multiple BLAST hits on the
zebrafish genome and with identical 55 bp alignments
were removed. Finally, 43,960 probes were designed for
7,903 CGIs in 6,024 genes. Slides were printed contain-
ing 45,220 features; 1,227 Agilent control features, 33
blank features and 43,960 probes. The array design was
named Agilent Birmingham D.rerio 025794 45220v1 and
is available from ArrayExpress under accession A-
MEXP-1813. Lists of genes with predicted CGIs and the
detailed criteria used for prediction of CGIs are pre-
sented in Additional file 5, Table S1. Probes were func-
tionally annotated from the zebrafish genome and
additional gene ontology (GO) terms were found using
Blast2GO [51].
The “Core Analysis” function included in Ingenuity
Pathway Analysis (IPA) (Ingenuity Systems Inc, USA)
[52] was used to aid interpretation of the hypo- and
hyper-methylated (fold change > 1.5) genes found by
comparison of zebrafish HCC with healthy liver. A Ben-
jamini and Hochberg multiple testing correction was
employed to determine significant enrichment of anno-
tation with biological functions and canonical pathways
among these gene sets.
Positive and Negative Controls
CpG methyltransferase (New England Biolabs, U.S.A)
was used to generate artificially methylated DNA from
zebrafish liver genomic DNA using S-adenosyl methio-
nine according to the manufacturer’s protocol. Briefly,
10×NEBuffer 2 (2 μl), S-adenosyl methionine (160 μM),
genomic DNA (1 μg) and SssI methylase (40 U/μl; New
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England Biolabs, U.S.A) were mixed in a total volume of
20 μl. The sample was incubated at 37°C for 4 h fol-
lowed by incubation at 65°C for 20 min for inactivation
of the enzyme.
A negative control for the array was generated by PCR
amplification of sonicated zebrafish liver genomic DNA.
DNA samples were amplified using GenomePlex Com-
plete Whole Genome Amplification (WGA) Kit (Sigma-
Aldrich, Poole, Dorset, U.K). PCR amplification removes
DNA methylation, resulting in an artificially un-methy-
lated DNA. Positive and negative control samples
were purified (Qiagen) prior to use in methyl-DNA
immunoprecipitation.
Methyl-DNA immunoprecipitation (MeDIP)
DNA from tumor, control, SAM-treated DNA (positive
control) and amplified DNA (negative control) were dis-
solved in TE buffer (6 μg in 300 μl) and fragmented to
200 bp-1 Kb using a sonicator (SONICS Vibra Cell, 100
watt, 3 × 10 s with 35 s intervals on ice with 20% ampli-
tude). Sizes of the generated fragments were checked on
a 1% agarose gel.
Methylated fragments of DNA were separated from
the un-methylated fragments using MagMeDIP kit
(Diagenode, Belgium) according to the manufacturer’s
instructions. DNA sample (1 μg) was used in each
immunoprecipitation. To avoid amplification bias, five
aliquots of each sample were immunoprecipitated and
combined. Samples were re-purified by phenol/chloro-
form/isoamyl alcohol extraction and precipitated with
ethanol and glycogen. DNA pellets were air dried and
stored at -80°C until subsequent use for labeling.
Sample labeling and hybridization to CGI (1.5 kb
downstream to 1 kb upstream of TSS) zebrafish
tiling array
The Agilent genomic DNA enzymatic labeling kit (Agi-
lent technologies, Berkshire, UK) and the protocol pro-
vided were used for labeling the immunoprecipitated
DNA with the fluorophore Cy-5 and zebrafish genomic
DNA with the fluorophore Cy-3. The specific activities
of the labeled samples were checked using a NanoDrop
spectrophotometer. Cy3-labeled genomic DNA samples
were pooled. For each hybridization, equal amounts (80
pmol incorporated) of Cy-3 labeled genomic DNA and
Cy-5 labeled immunoprecipitated DNA were mixed.
Microarray hybridization was performed using an Agi-
lent Oligo aCGH/Chip on chip hybridization kit accord-
ing to the manufacturer’s protocol. Briefly, the
hybridization mixes were loaded onto 4 × 44 K format
slides (Agilent Birmingham D.rerio 025794 45220v1)
hybridized overnight, washed, stabilized and dried. The
dried slides were scanned using an Axon 4000B laser
scanner (Molecular Devices, Wokingham, UK).
Statistical analysis
MIAME-compliant raw microarray data were submitted
to ArrayExpress at EMBL-EBI and can be found under
accession E-MTAB-209. GeneSpring v7.2 (Agilent) was
used for analyzing the data. Data flagged as present in
at least 4 of the 10 samples were used for analyses. The
Cy-5 test signal was divided by the control signal (geno-
mic pool) and each microarray was normalized to the
mean of the control group. Data with low raw intensity
(less than 25) or standard deviation greater than 1.4
between biological replicates were removed from the
analyses. Lists of hypo- and hyper- methylated genes
were generated using 1.5 fold change cut-offs and para-
metric Welch t-tests between tumor and healthy groups
(p-value <0.05) on the normalized data.
DNA methylation analysis using bisulfite sequencing PCR
The MethPrimer data base (MethPrimer - Li Lab,
UCSF) was used to design BSP primers (primer
sequences and annealing temperatures used are listed in
Additional file 1, Table S1). An artificially methylated
positive control was used for assessing complete conver-
sion of un-methylated cytosine to uracil after treatment
with bisulfite and methylation of all CpG dinucleotides.
The EZ DNA Methylation kit (Cambridge Biosciences,
UK) was used for bisulfite conversion according to man-
ufacturer’s protocol. Briefly, for each sample, 500 ng of
genomic DNA was bisulfite treated then amplified using
Zymo Taq DNA polymerase (Cambridge Biosciences,
UK). The PCR products were analyzed via DNA
gel electrophoresis followed by sequencing using an
ABI3730 DNA analyzer.
Additional material
Additional file 1: Table S1. Primers used in bisulfite sequencing
PCR. List of bisulfite sequencing primers (14 genes, 15 regions) used for
optimization of the immunoprecipitation method for HCC and healthy
zebrafish liver samples are shown in this table. Annealing temperatures,
product sizes and Ensembl gene IDs are shown.
Additional file 2: Optimization of bisulfite sequencing PCR. MeDIP
validation (Figures S1 and S2). Bisulfite sequencing of glutathione S-
transferase P1 gene (gstp1) (Figure S1) showed complete un-methylation
of the CpG dinucleotides. Bisulfite sequencing of the no-tail (ntla) gene
showed complete methylation of the CpG dinucleotides (Figure S2).
(Sequencing was performed on 4 independent samples; two tumor
samples and two control samples, arrows: cytosine located at CpG
dinucleotide site. Red peak: T, Blue peak: C) Validation of bisulfite
sequencing PCR (Figure S3). Glutathione S-transferase P1 gene is un-
methylated in both tumor and control. Treatment with CpG
methyltransferase (Sss I) in the presence of S-adenosylmethionine (SAM)
results in methylation of all CpG dinucleotides and protection against
conversion of 5-mC to U after treatment with bisulfite. Successful
bisulfite treatment and sequencing of the positive control was
established by observing a single C peak at the CpG dinucleotide
positions. (Two independent tumor samples, two independent control
samples). 1 = SAM positive control, 2 = control, 3 = control, 4 = tumor, 5
= tumor. Arrows: cytosine located at CpG dinucleotide site.
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Additional file 3: Table S1. Array data derived from comparison of
methylation level between HCC and healthy zebrafish liver were
confirmed using bisulfite sequencing PCR. Primer sequences, targeted
CpG islands, and annealing temperatures are shown in this table.
Additional file 4: Figure S1. Agarose gel electrophoresis image of
methyl-DNA immunoprecipitated (MeDIP) bisulfite treated ntla and
gstp1. The methylated ntla (a) gene is enriched after
immunoprecipitation, whereas the un-methylated gstp1 (b) gene is not
enriched.
Additional file 5: Table S1. CpG island prediction. A list of genes with
predicted CGIs, number of CGIs for each chromosome and location on
the chromosome are presented in additional file 5, Table S1.
Additional file 6: Full list of array data. Table S1: Fluorescence signals
of positive, artificially-methylated and negative, artificially un-methylated
immunoprecipitated controls relative to that of genomic DNA. Table S2:
Genes hypomethylated in tumor samples (> 1.5 fold). Table S3: Genes
hypermethylated in tumor samples (> 1.5 fold). Table S4: List of gene
methylation levels in control samples.
Additional file 7: Ingenuity Pathway Analysis of significantly altered
genes (fold change > 1.5 fold) in zebrafish hepatocellular
carcinoma compared to control achieved from MeDIP-tiling array.
Table S1: Functional categories enriched among hypermethylated genes
with FDR <5%. The categories, functional annotations and molecules
identified in each category are also presented. Table S2: Functional
categories enriched among hypomethylated genes with FDR <5%. The
categories, functional annotations and molecules identified in each
category are also presented.
Additional file 8: Table S1. List of genes (194) investigated for
comparison of DNA methylation level and gene expression level in
zebrafish HCC and healthy zebrafish liver. Genes highlighted in blue
(22) have significant changes in both gene expression and DNA methylation.
Additional file 9: Confirmation of the tiling array data using
bisulfite sequencing PCR. Figure S1: Shows relative increase in
methylation of coronin-actin binding protein 2ba in tumor compared with
control. Figure S2: Relative decrease in methylation of angiopoietin-like 3
in tumor compared with control. Figure S3: Relative decrease in
methylation of insulin-like growth factor binding protein 1b in tumor
compared with control. (1, 2 and 3: three independent controls, 4, 5 and
6: three independent tumors).
Additional file 10: Figure S1. Histopathology images of zebrafish
HCC and healthy zebrafish liver. A. Zebrafish liver section with
hepatocellular carcinoma (HCC) invasion into surrounding normal liver
tissue. HCC and surrounding normal tissue are labeled. B. Enlarged image
of the section indicated with a box in image A showing the boundary
between HCC and normal tissue. C. Normal control liver section. Normal
zebrafish hepatocytes are typically organized in two-cell thick plates and
are regular throughout the whole liver. Carcinomas lose this plate
architecture completely and are reorganized in typical patterns, such as a
trabecular pattern with several-cell thick irregular trabeculae, a glandular
pattern with a central clear space surrounded by one-cell layer neoplastic
hepatocytes, and a large sheet of neoplastic cells without any
recognizable pattern. Carcinoma cells are cuboidal with centrally
localized nuclei of variable sizes.
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